SEC Form 4Coverage since Jun 4, 2026
$MRNA insider trading
Over the last 12 months, Moderna insiders reported no purchases and 4 sales totaling $35.2M across SEC Form 4 filings. 100% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $35.2M 4 events
- Events · 12m
- 4 Form 4 filings, grouped
- Insiders · 12m
- 3 distinct reporters
- 10b5-1 share
- 100% pre-arranged plans
Side
Price · $MRNA · 12Mvia TradingView
Top insiders · 12m
Hoge StephenPresident2× · $6.3M
Klinger Shannon ThymeChief Legal Officer1× · $174K
Bancel StephaneChief Executive Officer1× · $28.7M
All insider trades
4 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Bancel StephaneChief Executive Officer · O·D | ▼ Sale | 499,246 | $57.52 | $28.7M | -7.5% | plan · 4 tranches |
| Jul 15, 2026 | Hoge StephenPresident · O | ▼ Sale | 53,336 | $67.6 | $3.6M | -3.5% | plan |
| Jun 15, 2026 | Hoge StephenPresident · O | ▼ Sale | 53,336 | $51.37 | $2.7M | -3.5% | plan |
| Jun 4, 2026 | Klinger Shannon ThymeChief Legal Officer · O | ▼ Sale | 3,471 | $50 | $174K | -4.9% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $MRNA feed.